JPS5314603B2 - - Google Patents

Info

Publication number
JPS5314603B2
JPS5314603B2 JP469475A JP469475A JPS5314603B2 JP S5314603 B2 JPS5314603 B2 JP S5314603B2 JP 469475 A JP469475 A JP 469475A JP 469475 A JP469475 A JP 469475A JP S5314603 B2 JPS5314603 B2 JP S5314603B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP469475A
Other languages
Japanese (ja)
Other versions
JPS50100213A (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS50100213A publication Critical patent/JPS50100213A/ja
Publication of JPS5314603B2 publication Critical patent/JPS5314603B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153Streptokinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • Y10S435/816Enzyme separation or purification by solubility

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
JP469475A 1974-01-11 1975-01-09 Expired JPS5314603B2 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US432789A US3865692A (en) 1974-01-11 1974-01-11 Method for making highly potent plasminogen

Publications (2)

Publication Number Publication Date
JPS50100213A JPS50100213A (cg-RX-API-DMAC7.html) 1975-08-08
JPS5314603B2 true JPS5314603B2 (cg-RX-API-DMAC7.html) 1978-05-18

Family

ID=23717599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP469475A Expired JPS5314603B2 (cg-RX-API-DMAC7.html) 1974-01-11 1975-01-09

Country Status (7)

Country Link
US (1) US3865692A (cg-RX-API-DMAC7.html)
JP (1) JPS5314603B2 (cg-RX-API-DMAC7.html)
CA (1) CA1017696A (cg-RX-API-DMAC7.html)
DE (1) DE2500810A1 (cg-RX-API-DMAC7.html)
FR (1) FR2258393B1 (cg-RX-API-DMAC7.html)
GB (1) GB1473245A (cg-RX-API-DMAC7.html)
SE (1) SE7500172L (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082612A (en) * 1976-09-24 1978-04-04 Michael Reese Research Foundation Plasminogen activator complex
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
JPS56106594A (en) * 1980-01-25 1981-08-24 Green Cross Corp:The Stabilizing method of plasminogen
GB2068002B (en) * 1980-01-25 1983-06-29 Green Cross Corp Plasminogen preparation and their production
JPS5716824A (en) * 1980-07-03 1982-01-28 Green Cross Corp:The Plasminogen pharmaceutical and stabilizing method thereof
EP0156169B1 (en) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method
US4774087A (en) * 1987-08-14 1988-09-27 Northwestern University Micro-size fibrinolytic plasmin
US5928772A (en) * 1996-06-13 1999-07-27 Dainippon Ink And Chemicals, Inc. Panel material and method of manufacturing the same
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
CA2726908C (en) * 2008-06-04 2017-01-24 Talecris Biotherapeutics, Inc. Composition, method, and kit for preparing plasmin
ES2552337T3 (es) 2009-03-03 2015-11-27 Grifols Therapeutics Inc. Procedimientos para la preparación de plasminógeno

Also Published As

Publication number Publication date
JPS50100213A (cg-RX-API-DMAC7.html) 1975-08-08
FR2258393B1 (cg-RX-API-DMAC7.html) 1978-06-23
GB1473245A (en) 1977-05-11
CA1017696A (en) 1977-09-20
AU7680974A (en) 1976-06-24
SE7500172L (cg-RX-API-DMAC7.html) 1975-07-14
FR2258393A1 (cg-RX-API-DMAC7.html) 1975-08-18
US3865692A (en) 1975-02-11
DE2500810A1 (de) 1975-07-17

Similar Documents

Publication Publication Date Title
FR2258393B1 (cg-RX-API-DMAC7.html)
DK139102C (cg-RX-API-DMAC7.html)
AU495883B2 (cg-RX-API-DMAC7.html)
CS169487B1 (cg-RX-API-DMAC7.html)
AU7459574A (cg-RX-API-DMAC7.html)
AU495844B2 (cg-RX-API-DMAC7.html)
AU485022B2 (cg-RX-API-DMAC7.html)
AU7099174A (cg-RX-API-DMAC7.html)
DE2444064A1 (cg-RX-API-DMAC7.html)
AU7253574A (cg-RX-API-DMAC7.html)
CS169374B1 (cg-RX-API-DMAC7.html)
BG19828A1 (cg-RX-API-DMAC7.html)
BG19690A1 (cg-RX-API-DMAC7.html)
DD117686A5 (cg-RX-API-DMAC7.html)
CH590561A5 (cg-RX-API-DMAC7.html)
CH589328A5 (cg-RX-API-DMAC7.html)
CH585975A5 (cg-RX-API-DMAC7.html)
BG19999A1 (cg-RX-API-DMAC7.html)
BG19987A1 (cg-RX-API-DMAC7.html)
BG19946A1 (cg-RX-API-DMAC7.html)
BG19908A1 (cg-RX-API-DMAC7.html)
BG19866A1 (cg-RX-API-DMAC7.html)
BG19917A1 (cg-RX-API-DMAC7.html)
BG19770A1 (cg-RX-API-DMAC7.html)
BG19766A1 (cg-RX-API-DMAC7.html)